Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2008

England P, Westblade LF, Karimova G, Robbe-Saule V, Norel F, Kolb A. Binding of the unorthodox transcription activator, Crl, to the components of the transcription machinery. J Biol Chem. 2008;283(48):33455-64.

Podsypanina K, Du Y-, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science. 2008;321(5897):1841-4.

Patnaik MM, Hammerschmidt D, van Burik J-, Jessurun J, Smyth P. Lepromatous leprosy masquerading as acute sarcoidosis: a case report and literature review. Minn Med. 2008;91(11):30-3.

Chen Y-, Tu JJ, Kao J, Zhou XK, Chen Y-. Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma. Arch Pathol Lab Med. 2008;132(2):224-31.

Magro CM, Dyrsen ME. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease. J Am Acad Dermatol. 2008;59(5):822-33.

Li Q, Estes JD, Duan L, Jessurun J, Pambuccian S, Forster C, et al. Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis. 2008;197(3):420-9.

Li M-, Sanchez T, Pappalardo A, Lynch KR, Hla T, Ferrer F. Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res. 2008;6(10):1649-56.

Perner S, Wagner PL, Demichelis F, Mehra R, Lafargue CJ, Moss BJ, et al. EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia. 2008;10(3):298-302.

Yemelyanova AV, Cosin JA, Bidus MA, Boice CR, Seidman JD. Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening. Int J Gynecol Cancer. 2008;18(3):465-9.

Secord AA, Blessing JA, Armstrong DK, Rodgers WH, Miner Z, Barnes MN, et al. Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study. Gynecol Oncol. 2008;108(3):493-9.